News & Media

• 18 Apr
  Cubist Reports 1Q12 Financial Results
  Wednesday Apr. 18th 2012
• 17 Apr
  CUBIST ANNOUNCES POSITIVE RESULTS FROM ENTEREG® PHASE 4 STUDY IN PATIENTS UNDERGOING RADICAL CYSTECTOMY
  Company Expects to File SNDA by End of 2012
  Tuesday Apr. 17th 2012
• 17 Jan
  Nothing bugs Cubist CEO Michael Bonney
  Loyalty, commitment and a cool head saves a money-making drug
  Tuesday Jan. 17th 2012

• View All News